Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BABA vs MRNA✓SelectedUSD · MRNABABA vs MRNA performance historyLatest closeAs of+0.02%11/13
Stock and ETF performance explorer

BABA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.9%
MRNA return
+221.0%
Excess return
-199.1%
Maximum drawdown
-49.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D0.0%-3.4%+3.5%+0.1%
7D-13.8%-12.1%-1.6%-13.4%
30D-15.1%-1.3%-13.8%-15.1%
3M-22.7%+250.9%-273.7%-26.9%
6M-34.7%+343.0%-377.7%-40.3%
YTD-35.0%+657.4%-692.5%-44.7%
1Y-40.4%+794.9%-835.3%-50.5%
3Y+21.9%+218.1%-196.2%+3.4%
All+21.9%+221.0%-199.1%+3.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling